A MURINE GASTRIC CANCER YTN16 MODEL FOR THE RATIONAL DESIGN OF COMBINATION IMMUNOTHERAPY

被引:0
|
作者
Nagaoka, Koji [1 ]
Sun, Changbo [1 ]
Kobayashi, Yukari [1 ]
Kakimi, Kazuhiro [1 ]
机构
[1] Univ Tokyo Hosp, Tokyo, Japan
关键词
D O I
10.1136/jitc-2021-SITC2021.913
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
913
引用
收藏
页码:A959 / A959
页数:1
相关论文
共 50 条
  • [41] Combination immunotherapy of an autochthonous murine lung cancer model expressing human CEA as a tumor-associated self-antigen
    Rakhra, Kavya
    Zhu, Eric F.
    Abraham, Wuhbet
    Moynihan, Kelly D.
    Mehta, Naveen
    Wittrup, Karl D.
    Irvine, Darrell J.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [42] A True Orthotopic Gastric Cancer Murine Model Using Electrocoagulation
    Bhullar, Jasneet Singh
    Makarawo, Tafadzwa
    Subhas, Gokulakkrishna
    Alomari, Ahmed
    Silberberg, Boris
    Tilak, Jacqueline
    Decker, Milessa
    Mittal, Vijay K.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (01) : 64 - 70
  • [43] Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination
    De Guillebon, Eleonore
    Dardenne, Antoine
    Saldmann, Antonin
    Seguier, Sylvie
    Tran, Thi
    Paolini, Lea
    Lebbe, Celeste
    Tartour, Eric
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (06) : 1509 - 1518
  • [44] Predicting response to combination evofosfamide and immunotherapy under hypoxic conditions in murine models of colon cancer
    Lima, Ernesto A. B. F.
    Song, Patrick N.
    Reeves, Kirsten
    Larimer, Benjamin
    Sorace, Anna G.
    Yankeelov, Thomas E.
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2023, 20 (10) : 17625 - 17645
  • [45] A QSP model of prostate cancer immunotherapy to identify effective combination therapies
    Roberta Coletti
    Lorena Leonardelli
    Silvia Parolo
    Luca Marchetti
    Scientific Reports, 10
  • [46] A QSP model of prostate cancer immunotherapy to identify effective combination therapies
    Coletti, Roberta
    Leonardelli, Lorena
    Parolo, Silvia
    Marchetti, Luca
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [47] Optimal control of combination immunotherapy for a virtual murine cohort in a glioblastoma-immune dynamics model
    Anderson, Hannah G.
    Takacs, Gregory P.
    Harrison, Jeffrey K.
    Rong, Libin
    Stepien, Tracy L.
    JOURNAL OF THEORETICAL BIOLOGY, 2024, 595
  • [48] Chemo-immunotherapy: Combination of temozolomide chemotherapy and dendritic cell vaccination in murine glioma model
    Hong, Yong-Kil
    Kim, Tai-Gyu
    NEURO-ONCOLOGY, 2007, 9 (04) : 505 - 505
  • [49] TARGETING DR5 IN BOTH MDSCS AND GASTRIC CANCER CELLS ENHANCES ANTI-PD-L1 ANTIBODY IMMUNOTHERAPY EFFICACY IN A GASTRIC CANCER MURINE MODEL.
    Tang, Yao
    Li, Qingli
    Wang, Jianzheng
    Huang, Tinglei
    Zhang, Baiwen
    Cheng, Xiaojiao
    Tu, Shuiping
    GASTROENTEROLOGY, 2019, 156 (06) : S374 - S374
  • [50] The use of Zymosan A and bacteria anchored to tumor cells for effective cancer immunotherapy: B16-F10 murine melanoma model
    Waldmannova, Eva
    Caisova, Veronika
    Faberova, Julie
    Svackova, Petra
    Kovarova, Marketa
    Svackova, Denisa
    Kumzakova, Zuzana
    Jackova, Adela
    Vacova, Nikol
    Nedbalova, Pavla
    Horka, Marie
    Kopecky, Jan
    Zenka, Jan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 39 : 295 - 306